Aprameya Engineering Ltd
Incorporated in September 2003, Aprameya Engineering Limited specializes in installing and maintaining Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centers.[1]
- Market Cap ₹ 282 Cr.
- Current Price ₹ 148
- High / Low ₹ 170 / 55.0
- Stock P/E 17.5
- Book Value ₹ 33.8
- Dividend Yield 0.00 %
- ROCE 31.1 %
- ROE 36.8 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has delivered good profit growth of 90.1% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 30.2%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 320 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 12 | 26 | 35 | 78 | 65 | 136 | |
| 11 | 24 | 25 | 69 | 59 | 111 | |
| Operating Profit | 2 | 2 | 10 | 9 | 6 | 24 |
| OPM % | 13% | 9% | 29% | 12% | 10% | 18% |
| 0 | 0 | 0 | 0 | 0 | 1 | |
| Interest | 1 | 1 | 0 | 2 | 2 | 3 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 2 | 10 | 7 | 5 | 22 |
| Tax % | 8% | 44% | 25% | 28% | 25% | 26% |
| 1 | 1 | 7 | 5 | 3 | 16 | |
| EPS in Rs | 10.66 | 3.84 | 2.47 | 8.47 | ||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 62% |
| 3 Years: | 57% |
| TTM: | 108% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 90% |
| 3 Years: | 29% |
| TTM: | 366% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 35% |
| 3 Years: | 30% |
| Last Year: | 37% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 7 | 14 | 14 | 19 |
| Reserves | 0 | 0 | 7 | 6 | 9 | 45 |
| 4 | 1 | 14 | 29 | 42 | 30 | |
| 6 | 5 | 20 | 13 | 10 | 49 | |
| Total Liabilities | 14 | 11 | 49 | 62 | 76 | 144 |
| 1 | 1 | 2 | 1 | 1 | 1 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| 13 | 10 | 47 | 60 | 74 | 143 | |
| Total Assets | 14 | 11 | 49 | 62 | 76 | 144 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 0 | 4 | 10 | -13 | -10 | -11 | |
| -1 | 0 | -0 | -2 | -1 | -0 | |
| 1 | -4 | -8 | 13 | 11 | 11 | |
| Net Cash Flow | 0 | -0 | 2 | -2 | 0 | -0 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 182 | 58 | 278 | 195 | 325 | 320 |
| Inventory Days | 245 | 122 | 455 | 376 | 74 | |
| Days Payable | 269 | 147 | 1,100 | 415 | 146 | |
| Cash Conversion Cycle | 159 | 33 | -367 | 157 | 253 | 320 |
| Working Capital Days | 160 | 50 | 204 | 195 | 319 | 231 |
| ROCE % | 35% | 59% | 25% | 12% | 31% |
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
17 May 2025 - Aprameya reports 108% revenue growth to INR136 Cr, margin improvement, INR60 Cr order book, and expansion plans.
-
Analysts/Institutional Investor Meet/Con. Call Updates
14 May 2025 - H2 and FY25 earnings call audio recording uploaded on company website on May 13, 2025.
-
Investor Presentation
8 May 2025 - Aprameya Engineering FY25 results: Rs 60 Cr order book, Rs 29.23 Cr IPO funds, expansion plans in healthcare infrastructure.
-
Press Release
8 May 2025 - Aprameya Engineering reports 108% revenue growth to Rs 1,363 Mn, PAT up 364%, expands into Maharashtra.
-
Analysts/Institutional Investor Meet/Con. Call Updates
8 May 2025 - Conference call scheduled on May 13, 2025, to discuss FY25 half year and full year earnings.
Annual reports
No data available.
Concalls
-
May 2025Transcript PPT
Business Segments
A) Healthcare Infrastructure Projects[1][2]
The company offers turnkey solutions for developing healthcare facilities, covering everything from design to execution of ICUs, NICUs, PICUs, Modular Operation Theatres (MOTs), Dialysis Centers, and Prefabricated Wards. The scope also includes integration of MEP systems, fire safety, structural design, and hospital interiors. These projects are tailored for public healthcare institutions, focused on customized infrastructure delivery.